• Return to Headlines

Recent 52-Week Low Surpassed in Shares of United Therapeut (UTHR)

By Amy Schwartz

Shares of United Therapeut (NASDAQ:UTHR) traded at a new 52-week low today of $77.56. Approximately 60,000 shares have changed hands today, as compared to an average 30-day volume of 899,000 shares.

United Therapeut has overhead space with shares priced $77.56, or 33.1% below the average consensus analyst price target of $116.00. The stock should run into initial resistance at its 50-day moving average (MA) of $93.62 and subsequent resistance at its 200-day MA of $111.39.

United Therapeut share prices have moved between a 52-week high of $130.00 and the current low of $77.56 and are currently at $77.56 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 2.5%.

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

SmarTrend recommended that its subscribers protect gains by selling shares of United Therapeut on April 9th, 2019 by issuing a Downtrend alert when the shares were trading at $111.97. Since that call, shares of United Therapeut have fallen 29.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows united therapeut

Ticker(s): UTHR